These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32514431)

  • 21. Management and monitoring of pediatric inflammatory bowel disease in the Asia-Pacific region: A position paper by the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations.
    Lee WS; Arai K; Alex G; Treepongkaruna S; Kim KM; Choong CL; Mercado KC; Darma A; Srivastava A; Aw MM;
    J Gastroenterol Hepatol; 2023 Apr; 38(4):510-522. PubMed ID: 36508314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul.
    Nakase H; Keum B; Ye BD; Park SJ; Koo HS; Eun CS
    Intest Res; 2016 Jul; 14(3):231-9. PubMed ID: 27433145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul.
    Kim ES; Chen M; Lee J; Lee CK; Kim YS
    Intest Res; 2016 Jul; 14(3):224-30. PubMed ID: 27433144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 in patients with inflammatory bowel disease.
    Anikhindi SA; Kumar A; Arora A
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1187-1193. PubMed ID: 32856955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
    Kennedy NA; Jones GR; Lamb CA; Appleby R; Arnott I; Beattie RM; Bloom S; Brooks AJ; Cooney R; Dart RJ; Edwards C; Fraser A; Gaya DR; Ghosh S; Greveson K; Hansen R; Hart A; Hawthorne AB; Hayee B; Limdi JK; Murray CD; Parkes GC; Parkes M; Patel K; Pollok RC; Powell N; Probert CS; Raine T; Sebastian S; Selinger C; Smith PJ; Stansfield C; Younge L; Lindsay JO; Irving PM; Lees CW
    Gut; 2020 Jun; 69(6):984-990. PubMed ID: 32303607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.
    Esposito S; Caminiti C; Giordano R; Argentiero A; Ramundo G; Principi N
    Front Immunol; 2022; 13():933774. PubMed ID: 35812420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A surgically relevant summary of the addendum to the S3 guidelines of the DGVS on Crohn's disease and ulcerative colitis : Treatment of chronic inflammatory bowel diseases in the COVID-19 pandemic].
    Grunert PC; Dignass A; Kucharzik T; Stallmach A; Sturm A; Schmidt C
    Chirurg; 2021 Jan; 92(1):30-33. PubMed ID: 33320280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence.
    Kumric M; Ticinovic Kurir T; Martinovic D; Zivkovic PM; Bozic J
    World J Gastroenterol; 2021 Jul; 27(25):3748-3761. PubMed ID: 34321841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic.
    Mastrangeli G; Vernia F; Necozione S; Muselli M; Frassino S; Cesaro N; Latella G; Fabiani L
    Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of inflammatory bowel disease-Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn's and Colitis meeting.
    Lee HH; Park JJ; Lee BI; Hilmi I; Sollano J; Ran ZH
    Intest Res; 2023 Jul; 21(3):328-338. PubMed ID: 37533264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.
    Ooi CJ; Hilmi I; Banerjee R; Chuah SW; Ng SC; Wei SC; Makharia GK; Pisespongsa P; Chen MH; Ran ZH; Ye BD; Park DI; Ling KL; Ong D; Ahuja V; Goh KL; Sollano J; Lim WC; Leung WK; Ali RAR; Wu DC; Ong E; Mustaffa N; Limsrivilai J; Hisamatsu T; Yang SK; Ouyang Q; Geary R; De Silva JH; Rerknimitr R; Simadibrata M; Abdullah M; Leong RW;
    Intest Res; 2019 Jul; 17(3):285-310. PubMed ID: 31146509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic.
    Kamath C; Brenner EJ
    Curr Res Pharmacol Drug Discov; 2022; 3():100101. PubMed ID: 35496814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory Bowel Disease Management during the COVID-19 Pandemic: A Literature Review.
    Hormati A; Arezoumand A; Dokhanchi H; Pezeshgi Modarres M; Ahmadpour S
    Middle East J Dig Dis; 2022 Apr; 14(2):155-166. PubMed ID: 36619145
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
    Tepasse PR; Vollenberg R; Nowacki TM
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management.
    Park DI; Hisamatsu T; Chen M; Ng SC; Ooi CJ; Wei SC; Banerjee R; Hilmi IN; Jeen YT; Han DS; Kim HJ; Ran Z; Wu K; Qian J; Hu PJ; Matsuoka K; Andoh A; Suzuki Y; Sugano K; Watanabe M; Hibi T; Puri AS; Yang SK
    Intest Res; 2018 Jan; 16(1):17-25. PubMed ID: 29422794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
    Scaldaferri F; Pugliese D; Privitera G; Onali S; Lopetuso LR; Rizzatti G; Settanni CR; Pizzoferrato M; Schiavoni E; Turchini L; Amatucci V; Napolitano D; Bernabei T; Mora V; Laterza L; Papa A; Guidi L; Rapaccini GL; Gasbarrini A; Armuzzi A
    United European Gastroenterol J; 2020 Aug; 8(7):775-781. PubMed ID: 32438878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SURGICAL MANAGEMENT OF ADULT CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN'S DISEASE AND COLITIS (GEDIIB).
    Zabot GP; Cassol OS; Quaresma AB; Gonçalves Filho FA; Baima JP; Imbrizi M; Rolim AS; Carmo AMD; Alves Junior AJT; Santos CHMD; Sobrado Junior CW; Miranda EF; Albuquerque IC; Souza MM; Kaiser Junior RL; Parra RS; Kotze PG; Saad-Hossne R
    Arq Gastroenterol; 2023; 59(suppl 1):1-19. PubMed ID: 36995887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment.
    Park DI; Hisamatsu T; Chen M; Ng SC; Ooi CJ; Wei SC; Banerjee R; Hilmi IN; Jeen YT; Han DS; Kim HJ; Ran Z; Wu K; Qian J; Hu PJ; Matsuoka K; Andoh A; Suzuki Y; Sugano K; Watanabe M; Hibi T; Puri AS; Yang SK
    Intest Res; 2018 Jan; 16(1):4-16. PubMed ID: 29422793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
    Nakase H; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Wagatsuma K; Yokoyama Y; Hisamatsu T
    Digestion; 2021; 102(5):814-822. PubMed ID: 32892197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A
    Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.